Transphorm, Inc. (TGAN)
Jun 20, 2024 - TGAN was delisted (reason: acquired by Renesas)
5.10
+0.34 (7.14%)
Last trade price

Transphorm Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Year Ending
TTM Mar 31, 2023Mar 31, 2022Dec 31, 2020Dec 31, 2019Dec 31, 2018
Cash & Equivalents
7.9516.0333.9414.692.883.07
Cash & Cash Equivalents
7.9516.0333.9414.692.883.07
Cash Growth
-66.38%-52.77%130.94%411.10%-6.32%-
Receivables
1.724.42.560.840.710.28
Inventory
10.018.416.331.630.990.85
Other Current Assets
1.281.861.971.060.780.62
Total Current Assets
20.9530.6944.7918.235.364.83
Property, Plant & Equipment
9.9910.921.651.321.772.13
Long-Term Investments
00.720.14000
Goodwill and Intangibles
1.121.41.82.392.643.26
Other Long-Term Assets
0.60.730.260.290.50.28
Total Long-Term Assets
11.7113.763.8544.915.67
Total Assets
32.6644.4548.6522.2310.2610.5
Accounts Payable
9.317.93.593.182.381.35
Deferred Revenue
0.0100.350.6703
Current Debt
0.3712.4020.1515.4610.35
Other Current Liabilities
2.731.641.352.682.851.83
Total Current Liabilities
12.4121.945.2926.6920.6916.53
Long-Term Debt
22.671215.3926.1715.85
Other Long-Term Liabilities
00.230000
Total Long-Term Liabilities
22.91215.3926.1715.85
Total Liabilities
14.4124.8417.2942.0846.8632.38
Total Debt
2.3715.071235.5541.6326.2
Debt Growth
-84.41%25.62%-66.24%-14.61%58.89%-
Retained Earnings
-242.15-209.24-178.64-161.82-143.92-128.63
Comprehensive Income
-1.93-1.43-1.2-0.77-0.74-0.74
Shareholders' Equity
18.2519.6231.36-19.86-122.25-107.54
Net Cash / Debt
5.580.9521.94-20.85-38.75-23.13
Net Cash / Debt Growth
-33.90%-95.66%----
Net Cash Per Share
0.090.020.48-0.66-1.38-5.48
Working Capital
8.548.7539.51-8.46-15.33-11.7
Book Value Per Share
0.290.350.68-0.63-4.34-25.49
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).